Effect of Dietary Fibre on Blood Glucose, Plasma Immunoreactive Insulin, C-peptide and GIP Responses in non Insulin Dependent (Type 2) Diabetics and Controls

2009 ◽  
Vol 215 (3) ◽  
pp. 205-213 ◽  
Author(s):  
BARBRO HAGANDER ◽  
BENGT SCHERSTÉN ◽  
NILS-GEORG ASP ◽  
GUNNAR SARTOR ◽  
CARL-DAVID AGARDH ◽  
...  
Keyword(s):  
Blood Glucose ◽  
Dietary Fibre ◽  
Immunoreactive Insulin ◽  
C Peptide ◽  
Type 2 Diabetics ◽  
Insulin Dependent ◽  
Plasma Immunoreactive Insulin ◽  
Glucose Plasma ◽  
Dependent Type

Do Postprandial Glucose Levels add Important Clinical Information When Fasting Glucose Levels are Near Normal in Non-Insulin-Dependent Patients with Type 2 Diabetes?

2009 ◽  
Vol 142 (6) ◽  
pp. 298-302
Author(s):  
Kerry D. Mansell ◽  
David F. Blackburn ◽  
Dean T. Eurich
Keyword(s):  
Type 2 Diabetes ◽  
Blood Glucose ◽  
Clinical Information ◽  
Postprandial Glucose ◽  
Target Range ◽  
Insulin Dependent ◽  
The Mean ◽  
Dependent Type ◽  
Diabetes Patients

Background: Practice guidelines recommend that both fasting and postprandial blood glucose measurements be performed to achieve glycemic targets, yet few type 2 diabetes patients engage in postprandial glucose (PPG) testing. The purpose of this study was to determine if PPG testing provides important additional clinical information beyond fasting plasma glucose (FPG) tests in well-controlled, non-insulin-dependent type 2 diabetes patients. Methods: Subjects were recruited from 8 pharmacies and instructed to perform daily FPG tests during days 1 to 7 (run-in phase) and daily FPG and PPG tests during days 8 to 21 (test phase). Results: The mean FPG from 362 tests ( n = 52 subjects) in the run-in phase was 7 mmol/L (SD 1.4). In the test phase, the mean FPG was 7 mmol/L (SD 1.6) and the mean PPG was 8.4 mmol/L (SD 2.2) from 700 tests. For FPG tests in the recommended target range of 4 to 7 mmol/L, 87% (322/370) of corresponding (same-day) PPG tests were within the target range of 5 to 10 mmol/L. In subjects whose mean FPG was 4 to 7 mmol/L, 87% of PPG tests were also within target limits. Conclusion: Community pharmacists are often asked by patients how frequently they should be monitoring their blood glucose, but the evidence supporting self-monitoring of blood glucose (SMBG) in non-insulin-dependent type 2 diabetes patients is conflicting and unclear. Given the results from this small study, testing PPG may be unnecessary for non-insulin-dependent type 2 diabetes patients achieving FPG targets, but further study is required.

Body Weight Modulates Cholesterol Metabolism in Non-Insulin Dependent Type 2 Diabetics

2002 ◽  
Vol 10 (5) ◽  
pp. 328-335 ◽  
Author(s):  
Piia P. Simonen ◽  
Helena Gylling ◽  
Tatu A. Miettinen
Keyword(s):  
Body Weight ◽  
Cholesterol Metabolism ◽  
Type 2 Diabetics ◽  
Insulin Dependent ◽  
Dependent Type

Effect of Correction of Hyperglycemia on Left Ventricular Function in Non-Insulin-Dependent (Type 2) Diabetics

2009 ◽  
Vol 213 (5) ◽  
pp. 363-368 ◽  
Author(s):  
Matti Uusitupa ◽  
Onni Siitonen ◽  
Antti Aro ◽  
Timo Korhonen ◽  
Kalevi Pyórälä
Keyword(s):  
Left Ventricular Function ◽  
Ventricular Function ◽  
Left Ventricular ◽  
Type 2 Diabetics ◽  
Insulin Dependent ◽  
Dependent Type

Corrigendum: Training-induced alterations of skeletal muscle mitochondrial biogenesis proteins in non-insulin-dependent type 2 diabetic men

2016 ◽  
Vol 94 (1) ◽  
pp. 117-117
Author(s):  
Nana Chung ◽  
Thorsten Kreutz ◽  
Thorsten Schiffer ◽  
David Opitz ◽  
Robin Hermann ◽  
...  
Keyword(s):  
Skeletal Muscle ◽  
Mitochondrial Biogenesis ◽  
Insulin Dependent ◽  
Type 2 Diabetic ◽  
Dependent Type
Sign in / Sign up

Export Citation Format

Share Document